These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 6279280)

  • 1. Implementation of micromethods to resolve problems of human breast tumor heterogeneity in analysis of cyclic 3':5'-nucleotide phosphodiesterase.
    Larner EH; Rutherford CL
    Cancer Res; 1982 May; 42(5):1661-8. PubMed ID: 6279280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taste bud adenosine -3'5'-monophosphate phosphodiesterase: activity, subcellular distribution and kinetic parameters.
    Law JS; Henkin RI
    Res Commun Chem Pathol Pharmacol; 1982 Dec; 38(3):439-52. PubMed ID: 6298918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
    Kelly JJ; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3',5'-Cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition.
    Drees M; Zimmermann R; Eisenbrand G
    Cancer Res; 1993 Jul; 53(13):3058-61. PubMed ID: 8391385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Differences in the Ca2+- and calmodulin-sensitivity of cyclic nucleotide phosphodiesterase [PDE] in microtubule preparations from brain and Ehrlich-ascites-tumor cells [EAT]].
    Künkel W; Römer W; Wohlrabe K
    Acta Histochem Suppl; 1983; 27():311-6. PubMed ID: 6306728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple forms of cyclic nucleotide phosphodiesterase in a murine adrenal cortex cell line (Y-1).
    Ryan JA; Toscano WA
    Arch Biochem Biophys; 1985 Sep; 241(2):403-12. PubMed ID: 2994565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity. Selective effect of cyclic AMP.
    Maurice DH
    Cell Biochem Biophys; 1998; 29(1-2):35-47. PubMed ID: 9631237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ca2+-calmodulin-activated cyclic nucleotide phosphodiesterase from the soluble fraction of the human brain: Kinetic properties and the effect of the antidepressant pyrazidol and its nitro analog on the enzyme].
    Medvedeva MV; Belov AA; Kireeva NN; Bobruskin ID
    Biokhimiia; 1993 May; 58(5):798-808. PubMed ID: 8393348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of 3',5' cyclic nucleotide phosphodiesterase activity in Y79 retinoblastoma cells: absence of functional PDE6.
    White JB; Thompson WJ; Pittler SJ
    Mol Vis; 2004 Oct; 10():738-49. PubMed ID: 15480303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apoptosis by an inhibitor of cAMP-specific PDE in malignant murine carcinoma cells overexpressing PDE activity in comparison to their nonmalignant counterparts.
    Marko D; Romanakis K; Zankl H; Fürstenberger G; Steinbauer B; Eisenbrand G
    Cell Biochem Biophys; 1998; 28(2-3):75-101. PubMed ID: 9515161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and characterization of deletion recombinants of two cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE-3).
    He R; Komas N; Ekholm D; Murata T; Taira M; Hockman S; Degerman E; Manganiello VC
    Cell Biochem Biophys; 1998; 29(1-2):89-111. PubMed ID: 9631240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic AMP phosphodiesterase (PDE) in microtubule preparations. I. The influence of calmodulin and Ca2+ on the PDE activity.
    Künkel W; Römer W
    Acta Histochem Suppl; 1983; 27():303-9. PubMed ID: 6306726
    [No Abstract]   [Full Text] [Related]  

  • 13. Properties of hepatic and pancreatic cyclic AMP phosphodiesterase in the cat.
    Sakane Y; Morgan PR; Glenn TM
    Res Commun Chem Pathol Pharmacol; 1981 Nov; 34(2):251-66. PubMed ID: 6278552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of PDE5 and PDE9 expression in benign and malignant breast tumors.
    Karami-Tehrani F; Moeinifard M; Aghaei M; Atri M
    Arch Med Res; 2012 Aug; 43(6):470-5. PubMed ID: 22960860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic nucleotide phosphodiesterases in normal and malignant human tissues.
    Stefanovich V; Ambrus JL; Ambrus CM; Karakousis C; Takita H
    J Med; 1981; 12(4):243-50. PubMed ID: 6273486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and stabilization of large molecular weight PDE-IVs from U937 cells.
    DiSanto ME; Heaslip RJ
    Biochem Biophys Res Commun; 1993 Dec; 197(3):1126-31. PubMed ID: 8280127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in cyclic 3',5'-adenosine monophosphate phosphodiesterase activity in exudate and cultured mouse peritoneal macrophages.
    Zendegui JG; Klein TW
    J Reticuloendothel Soc; 1982 Jun; 31(6):455-67. PubMed ID: 6288938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
    Matsumori A; Ono K; Sato Y; Shioi T; Nose Y; Sasayama S
    J Mol Cell Cardiol; 1996 Dec; 28(12):2491-9. PubMed ID: 9004165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells.
    Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
    Biochem Pharmacol; 2005 Jan; 69(2):267-75. PubMed ID: 15627479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma membrane-bound cyclic AMP phosphodiesterase activity in 3T3-L1 adipocytes.
    Zhang X; Carey GB
    Comp Biochem Physiol B Biochem Mol Biol; 2004 Mar; 137(3):309-16. PubMed ID: 15050518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.